Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $42,331 | $41,518 | $199 | $174 |
| Dep. & Amort. | $13,143 | $8,687 | $59 | $63 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$4,181 | -$8,877 | -$44 | $1 |
| Other Non-Cash | -$14,376 | -$7,083 | $30,711 | $27,012 |
| Operating Cash Flow | $36,917 | $34,245 | $233 | $224 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,080 | -$8,912 | -$75 | -$93 |
| Net Acquisitions | -$74,479 | $0 | $1 | -$10 |
| Inv. Purchases | -$9,537 | -$9,080 | -$45 | -$46 |
| Inv. Sales/Matur. | $5,974 | $1,704 | $20 | $16 |
| Other Inv. Act. | -$2,048 | -$29 | -$13,077 | -$16,273 |
| Investing Cash Flow | -$89,170 | -$16,317 | -$13,176 | -$16,406 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $31,907 | -$1,223 | -$9,882 | $7,590 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$5,000 | $0 | $0 | $0 |
| Dividends Paid | -$7,072 | -$5,475 | -$4,676 | -$3,422 |
| Other Fin. Act. | $15,484 | -$7,086 | -$1,641 | -$698 |
| Financing Cash Flow | $35,319 | -$13,784 | -$16,199 | $3,470 |
| Forex Effect | $3,374 | $4,703 | $5,236 | $4,335 |
| Net Chg. in Cash | -$13,341 | $8,871 | $6,786 | $18,651 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $86,562 | $77,691 | $582 | $473 |
| End Cash | $73,221 | $86,562 | $585 | $582 |
| Free Cash Flow | $26,356 | $25,333 | $158 | $131 |